Pfizer trims 2026 profit forecast amid Covid headwinds and patent cliff pressures - Pharmaceutical Technology

Patents, Intellectual Property News

Pfizer has set its FY2026 profit forecast below analyst estimates, blaming projected losses on waning Covid vaccine sales and the looming patent cliff ...

Related articles